ERIN MERRELL: Open Payments
NPI 1992214076 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$799 in 46 payments from 17 companies in 2025. Trend: 2023 $55 · 2024 $175 · 2025 $799
Food & beverage: $799
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $150 |
| Lilly USA, LLC | 11 | $140 |
| Tonix Medicines, Inc. | 1 | $84 |
| AstraZeneca Pharmaceuticals LP | 4 | $61 |
| Astellas Pharma US Inc | 2 | $60 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $56 |
| ABBVIE INC. | 3 | $44 |
| Radius Health, Inc. | 2 | $30 |
| Organon LLC | 1 | $25 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $25 |
Products named: Ozempic, MOUNJARO, Veozah, Kerendia, JARDIANCE, AIRSUPRA, Tymlos, UBRELVY.
Industry payments across NE — which companies pay providers there.
